Terveystalo shares fell sharply in Helsinki trading, dropping approximately 12% after the company issued a profit warning for the full year.
The private healthcare provider announced it is lowering its adjusted operating profit (EBIT) guidance to a range of EUR 120 million to EUR 140 million, a significant downward revision that caught investors off guard.
The market reaction was immediate and severe, reflecting concerns over the sustainability of the company’s revenue model amid softer-than-expected patient volumes.
The sell-off underscores the sensitivity of healthcare equities to operational guidance, particularly when demand-side pressures persist across key outpatient segments.
Analysts note that the drivers behind the warning are familiar themes for the sector.
Roni Peuranheimo, an analyst at Inderes, described the underlying cause as "exceptionally weak demand," suggesting that the issue is not a one-off anomaly but a structural challenge affecting the business.